Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lacosamide generics availability?Semaglutide injection patent?Norelgestromin ethinyl estradiol coupon?Trelegy ellipta coupon?Semaglutide discovery history?
See the DrugPatentWatch profile for Synjardy
Synjardy is the brand name for the diabetes medicine with the generic name empagliflozin/metformin (a combination of empagliflozin plus metformin).
Synjardy specifically refers to the combination product. You may also see the same combination described by its components—empagliflozin + metformin—or as empagliflozin/metformin. The exact “Synjardy” product form (immediate-release vs extended-release) can affect labeling details, but the combination stays the same.
A “generic Synjardy” would use the same active ingredients: empagliflozin/metformin. The availability of approved generics can depend on patent/litigation status and FDA approvals. DrugPatentWatch.com tracks such issues for many products; you can check there for Synjardy-related exclusivity and patent updates: https://www.drugpatentwatch.com/
You may also see Synjardy XR, which uses the same generic combination (empagliflozin/metformin) but with a different formulation (extended-release for the metformin component). Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Synjardy :